CHPA Pushes Federal Legislation, PSAs To Curb Dextromethorphan Abuse
This article was originally published in The Tan Sheet
Executive Summary
The Consumer Healthcare Products Association is actively working to encourage introduction of companion legislation in the Senate for a bill that would restrict the sale and distribution of bulk forms of dextromethorphan
You may also be interested in...
Bill To Restrict Bulk DXM Sales Reintroduced In House
Legislation reintroduced by Reps. Fred Upton, R-Mich., and Rick Larsen, D-Wash., Feb. 8 would restrict online sales of bulk dextromethorphan to entities registered with FDA, but does not propose methods of preventing abuse of OTC cough medicines
Bill To Restrict Bulk DXM Sales Reintroduced In House
Legislation reintroduced by Reps. Fred Upton, R-Mich., and Rick Larsen, D-Wash., Feb. 8 would restrict online sales of bulk dextromethorphan to entities registered with FDA, but does not propose methods of preventing abuse of OTC cough medicines
Bill To Restrict Bulk DXM Sales Reintroduced In House
Legislation reintroduced by Reps. Fred Upton, R-Mich., and Rick Larsen, D-Wash., Feb. 8 would restrict online sales of bulk dextromethorphan to entities registered with FDA, but does not propose methods of preventing abuse of OTC cough medicines